Hims and Hers' stock fell over 19% in after-hours trading on Monday after its CEO said the company would no longer sell compounded versions of mega-hit weight loss drugs. "We will have to start ...
Many treatments are available, and with the popularity of online and mail-order services in recent years, two leaders are BlueChew and Hims. Both companies offer different ED treatments and a ...
Hims & Hers (HIMS) stock is sinking 20% today after Eli Lilly (LLY) unveiled significantly cheaper versions of its popular weight-loss drugs today. Additionally, the FDA last week hindered the ...
Telehealth company Hims & Hers Health (NYSE:HIMS) announced in Q4 CY2024, with sales up 95.1% year on year to $481.1 million. On top of that, next quarter’s revenue guidance ($530 million at the ...
Hosted on MSN23d
Why Is Hims & Hers Health (HIMS) Stock Rocketing Higher TodayHims & Hers Health’s shares are extremely ... But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas ...
Hims & Hers Health's stock has surged 205% since ... in website and mobile application development and internal-use software" investments in CapEx) gives the stock a price/FCF multiple of ~105x ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback